respiratory drugs

44
RESPIRATORY DRUGS -DR.AKIF A.B STEP TO PG- MD/MS- DR.AKIF A.B

Upload: akifab93

Post on 11-Apr-2017

41 views

Category:

Health & Medicine


0 download

TRANSCRIPT

Page 1: Respiratory drugs

RESPIRATORY DRUGS-DR.AKIF A.B

STEP TO PG-MD/MS-DR.AKIF A.B

Page 2: Respiratory drugs

BRONCHIAL ASTHMABeta 2 agonists Salbutamol, Salmeterol,terbutaline,

formoterol

Anticholinergics Ipratropium, Tiotropium

Methylxanthines Theophylline (Deriphylline)

Corticosteroids

Leukotriene pathway inhibitors Monteleukast, Zafirleukast

Mast cell stabilisers Cromolyn sodium, nedocromil sodium, Ketotifen

Anti Ig E monoclonal antibody Omalizumab

STEP TO PG-MD/MS-DR.AKIF A.B

Page 3: Respiratory drugs

BRONCHIAL ASTHMA

Histamine

Activates T helper-2 cells to release IL-4

IL-4 induces IgE production by plasma cells

IgE binds to Mast cells

Mast cell degranulation releases

Inflammatory mediators

Arachidonic acid

Allergen

LT-C4/D4/E4

Bronchoconstriction

LOXChronic

InflammationSTEP TO PG-MD/MS-DR.AKIF A.B

Page 4: Respiratory drugs

RESPIRATORY DRUGS1) Long acting β2 adrenoreceptor agonist: (AIIMS Nov. 2009)

A Salmeterol

B Orciprenaline

C Penoterol

D Pexbaterol

STEP TO PG-MD/MS-DR.AKIF A.B

Page 5: Respiratory drugs

Ans. A Salmeterol

Salmeterol: It is the long acting selective β2 agonist with a slow onset of action;

used by inhalation on a twice-daily schedule for maintenance therapy and for nocturnal asthma, but not for acute symptoms.

STEP TO PG-MD/MS-DR.AKIF A.B

Page 6: Respiratory drugs

BRONCHODILATORSBeta 2 Agonists + Beta 2 receptor M3 receptor

Anticholinergics(-)

Increase C-AMP

Decrease Ca++

Increase Ca++

Bronchoconstriction

Bronchodilation

PDE5’AMP

Methylxanthines(-)

STEP TO PG-MD/MS-DR.AKIF A.B

Page 7: Respiratory drugs

BETA 2 AGONISTSShort acting Beta Agonists(SABA)

Features Long acting Beta Agonists(LABA)

Salbutamol Given by inhalational route

Salmeterol

Terbutaline Given by subcutaneous route

Formoterol

Levalbuterol Most potent SABA

STEP TO PG-MD/MS-DR.AKIF A.B

Page 8: Respiratory drugs

BETA 2 AGONISTSSIDE EFFECTS

1) Tremors : MC Side effect

2) Hypokalemia

3) Hyperglycemia

4) QT Prolongation

STEP TO PG-MD/MS-DR.AKIF A.B

Page 9: Respiratory drugs

ANTI CHOLINERGICS1)Ipratropium= Short acting

2) Tiotropium = Longest acting

-Acts by inhibiting M3 receptors

-Bronchodilator of choice in COPD

-Side effects : Dry mouth(MC), Urinary retention

STEP TO PG-MD/MS-DR.AKIF A.B

Page 10: Respiratory drugs

METHYLXANTHINES-Theophylline

-Inhibits Phophodiesterase 3 and 4 and thus prevents conversion of cAMP to 5’AMP and thus leads to Increase cAMP

-Dose : 8mg/kg for oral route

6mg/kg for I.V route

-Low therapeutic index

-Normal therepautic range : 5-15mg/L

STEP TO PG-MD/MS-DR.AKIF A.B

Page 11: Respiratory drugs

Thereupatic Drug Monitoring is done

for-Low =Lithium

-Thereupatic =Theophylline

-Index = Immunosuppressants (Cyclosporine and tacrolimus)

-Thereupatic = TCAs

-Drug = Digitalis

-Administration = Aminoglycosides/AntiepilepticsSTEP TO PG-MD/MS-DR.AKIF A.B

Page 12: Respiratory drugs

METHYLXANTHINES S/E1)Cardiac Arrhythmias (MC)

2)Seizures

3)Hypokalemia

4)Hyperglycemia

STEP TO PG-MD/MS-DR.AKIF A.B

Page 13: Respiratory drugs

RECENT ADVANCES1) Magnesium is used as bronchodilator since it causes inhibition of calcium transport into smooth muscle cell.

2) Cromakalin is a potassium channel opener under trial for asthma.

3) Aprepitant : It is an NK1 antagonist under trial for treatment for cough associated with Bronchial cancer

4) Baclofen : GABA-B agonist is also known to have Antitussive effect

STEP TO PG-MD/MS-DR.AKIF A.B

Page 14: Respiratory drugs

2. Which of the following acts as a leukotriene receptor antoagonist? (AIIMS May 2011)

A Zafirlukast

B Zileuton

C Cromolyn sodium

D Deriphylline

STEP TO PG-MD/MS-DR.AKIF A.B

Page 15: Respiratory drugs

Ans. A Zafirlukast

a. Used for mild to moderate asthma

f. Short duration of action and hepatotoxic potential limit it's use.

STEP TO PG-MD/MS-DR.AKIF A.B

Page 16: Respiratory drugs

LEUKOTRIENE RECEPTORANTAGONISTS

-Monteleukast

-Zafirlukast

-5-LOX (5 Lipo-oxygenase) inhibitor: Zileuton

-S/E :Churg Strauss Sx

STEP TO PG-MD/MS-DR.AKIF A.B

Page 17: Respiratory drugs

Zileuton:Lipooxygenase Inhibitor

Leukotriene receptor antagonists

STEP TO PG-MD/MS-DR.AKIF A.B

Page 18: Respiratory drugs

3. Which one of the following is a side effect of beta2 agonist? (AIIMS May 2010)

A Hypoglycemia

B Hypomagnesemia

C Hypophosphatemia

D Hypokalemia

STEP TO PG-MD/MS-DR.AKIF A.B

Page 19: Respiratory drugs

Ans. D Hypokalemia Beta2 agonists like salbutamol and terbutaline can cause several adverse effects like :

a. Tachycardia due to stimulation of chronotropic Βeta2 receptors and at high dose due to stimulation of Βeta1 receptors also.

b. Tremors may result due to stimulation of muscle spindles.

c. Tolerance may develop due to densensitization of receptors.

d. Transient hyperkalemia followed by prolonged hypokalemia is seen on continued use.

e. Hyperglycemia may develop due to release of glucagon and stimulation of glycogenolysis and gluconeogenesis.

STEP TO PG-MD/MS-DR.AKIF A.B

Page 20: Respiratory drugs

BETA 2 AGONISTSSIDE EFFECTS

1) Tremors : MC Side effect

2) Hypokalemia

3) Hyperglycemia

4) QT Prolongation

STEP TO PG-MD/MS-DR.AKIF A.B

Page 21: Respiratory drugs

4. A predictably dangerous side effect of nadolol that constitutes a contraindication to its clinical use in susceptible patients is the induction of

A Hypertension

B Cardiac arrhythmia

C Asthmatic attacks

D Respiratory depression

STEP TO PG-MD/MS-DR.AKIF A.B

Page 22: Respiratory drugs

Ans. C Asthmatic attacks

The chief danger of therapy with beta -adrenergic blocking agents, such as nadolol and propranolol, is associated with the blockade itself.

Beta adrenergic blockade results in an increase in airway resistance that can be fatal in asthmatic patients.

Hypersensitivity reactions such as rash, fever, and purpura are rare and necessitate discontinuation of therapy

STEP TO PG-MD/MS-DR.AKIF A.B

Page 23: Respiratory drugs

SABA (DOC)

Acute attack Persistent Prophylaxis

Asthma

ICS (DOC) LABA (DOC)

Systemic corticosteroids

Oranticholinergics

I.V Aminophylline

Add LABA Cromolyn

NR

NR

NR NR

NR –No ResponseSTEP TO PG-MD/MS-DR.AKIF A.B

Page 24: Respiratory drugs

CORTICOSTEROIDS-Decreases chronic inflammation by their anti inflammatory effect

-DOC in :1) persistent bronchial asthma

2) Prophylaxis of Exercise Induced Asthma

INHALATIONAL CORTICOSTEROIDS

1) Beclomethasone

2) Ciclesonide

3) Triamcinolone

4) Fluticasone

STEP TO PG-MD/MS-DR.AKIF A.B

Page 25: Respiratory drugs

CORTICOSTEROIDS-All inhalational corticosteroids except Beclomethasone and Triamcinolone undergoes extensive first pass metabolism and hence produces less systemic toxicity.

-Most potent Inhalational Cortiocosteroid : Fluticasone

-MC S/E of ICS : Hoarseness of voice > Oropharyngeal candidiuasis

Soft Steroids-Prodrugs which are activated by acetylation in Lungs

-E.g: Beclomethasone

- Ciclesonide

STEP TO PG-MD/MS-DR.AKIF A.B

Page 26: Respiratory drugs

DRUGS FOR PULMONARY HYPERTENSION

Calcium channel blockers

Endothelin antagonists

PGI2 Analogs Phosphodiesterase-5 Inhibitors

Bosentan

Ambrisentan

Epoprostenol

Ileoprost

Teprostinil

Sildenafil

Tadafil

Best antihypertensive for treatment of PAH.

DOC for class II & III PAH (Low Risk)

Best drug for treatment of PAH

-DOC for class IV PAH (High risk)

Sildenafil is the DOC for Erectile Dysfunction

STEP TO PG-MD/MS-DR.AKIF A.B

Page 27: Respiratory drugs

ANTITUSSIVESCentrally acting drugs

Features Peripherally acting drugs

Features

OpioidsCodeinePholcodeineMorphine methadone

-acts by inhibiting mu receptors

Local anaesthetics

Lidocaine andBupivacaine is used topically

-Mexilitene by oral route

Dextromethorphan

-NMDA receptor Inhibitor- S/E: Hallucination & Addiction

Cromolyn Effective in ACEIs associated cough

Diphenylhydramine

S/E: SedationAnticholinergic effect

Moguistine

Caramiphen

Page 28: Respiratory drugs

OPIOIDS-Antitussive of choice = Codeine

-Mild to moderate cough = codeine and pholcodeine

-Severe persistent cough of bronchial cancer = Morphine and methadone

-MC S/E : Constipation

STEP TO PG-MD/MS-DR.AKIF A.B

Page 29: Respiratory drugs

MUCOLYTICS-These liquifies mucus in respiratory tract and facilitates removal.

-Acetylcysteine

-Bromhexine

-Ambroxol

-These 2 drugs acts by breaking the Disulfide bond

STEP TO PG-MD/MS-DR.AKIF A.B

Page 30: Respiratory drugs

EXPECTORANTS-These are drugs that increase removal of secretion from respiratory tract by due to reflex stimulation caused by Gastric irritation.

- Guaifenesin

STEP TO PG-MD/MS-DR.AKIF A.B

Page 31: Respiratory drugs

CONDITION DOCAllergic bronchopulmonary aspergillosis

Prednisolone

Cryptogenic organising Pneumonia Prednisolone

Sarcoidosis Prednisolone

Acute attack of asthma SalbutamolProphylaxis of asthma LABAExercise induced asthma Inhalational corticosteroids

Persistent asthma Inhalational corticosteroids

Brittle asthma Epinephrine

DRUG OF CHOICESTEP TO PG-MD/MS-DR.AKIF A.B

Page 32: Respiratory drugs

CONDITION DOCChylothorax Octreotide via chest tubeCOPD Anticholinergics(Tiotropium)

Non specific Cough CodeineBronchial cancer induced cough Morphine

Pleurodesis DoxycyclinePericardiodesis Doxycycline

Pulmonary edema (Diuretic of choice) Loop diuretics

Class II & III PAH BosentanClass IV PAH Epoprostenol

DRUG OF CHOICESTEP TO PG-MD/MS-DR.AKIF A.B

Page 33: Respiratory drugs

NEW DRUGSNEW DRUG

Pirfenedone Idiopathic pulmonary fibrosis

Nintedanib Idiopathic pulmonary fibrosis

Umeclidinium COPD

Oladetrol COPD

Ivacaflor Cystic fibrosis

Rufilomilast COPD

STEP TO PG-MD/MS-DR.AKIF A.B

Page 34: Respiratory drugs

INHALATIONAL DEVICES-Size of Drug particle appropriate for inhalational route is 2-5microns

1) Metered dose inhaler

2) Dry powder inhalers

3) Nebulisers

STEP TO PG-MD/MS-DR.AKIF A.B

Page 35: Respiratory drugs

METERED DOSE INHALER

STEP TO PG-MD/MS-DR.AKIF A.B

Page 36: Respiratory drugs

DRY POWDER INHALERS

STEP TO PG-MD/MS-DR.AKIF A.B

Page 37: Respiratory drugs

NEBULISERS

STEP TO PG-MD/MS-DR.AKIF A.B

Page 38: Respiratory drugs

STEP TO PG-MD/MS-DR.AKIF A.B

Page 39: Respiratory drugs

NASAL CANNULA

STEP TO PG-MD/MS-DR.AKIF A.B

Page 40: Respiratory drugs

SIMPLE OXYGEN MASK

STEP TO PG-MD/MS-DR.AKIF A.B

Page 41: Respiratory drugs

VENTURI MASK

STEP TO PG-MD/MS-DR.AKIF A.B

Page 42: Respiratory drugs

NON BREATHING MASK

STEP TO PG-MD/MS-DR.AKIF A.B

Page 43: Respiratory drugs

FACE TENT

STEP TO PG-MD/MS-DR.AKIF A.B

Page 44: Respiratory drugs

STEP TO PG-MD/MS-DR.AKIF A.B

STEP TO PG-MD/MS-DR.AKIF A.B